nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—CYP1A2—Carmustine—lymphatic system cancer	0.239	0.47	CbGbCtD
Rotigotine—CYP3A4—Cytarabine—lymphatic system cancer	0.0855	0.168	CbGbCtD
Rotigotine—CYP3A4—Teniposide—lymphatic system cancer	0.0842	0.166	CbGbCtD
Rotigotine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0589	0.116	CbGbCtD
Rotigotine—CYP3A4—Vincristine—lymphatic system cancer	0.0405	0.0797	CbGbCtD
Rotigotine—Skin exfoliation—Carmustine—lymphatic system cancer	0.00435	0.00885	CcSEcCtD
Rotigotine—Vertigo—Mechlorethamine—lymphatic system cancer	0.00432	0.00878	CcSEcCtD
Rotigotine—Disorientation—Bleomycin—lymphatic system cancer	0.00424	0.00862	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Fludarabine—lymphatic system cancer	0.00415	0.00844	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.00406	0.00826	CcSEcCtD
Rotigotine—Abnormal vision—Carmustine—lymphatic system cancer	0.00397	0.00808	CcSEcCtD
Rotigotine—Infection—Mechlorethamine—lymphatic system cancer	0.00389	0.00792	CcSEcCtD
Rotigotine—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00381	0.00774	CcSEcCtD
Rotigotine—Swelling—Carmustine—lymphatic system cancer	0.00375	0.00763	CcSEcCtD
Rotigotine—Anorexia—Mechlorethamine—lymphatic system cancer	0.00374	0.0076	CcSEcCtD
Rotigotine—Sinusitis—Fludarabine—lymphatic system cancer	0.00374	0.0076	CcSEcCtD
Rotigotine—Swelling—Mitoxantrone—lymphatic system cancer	0.00349	0.00709	CcSEcCtD
Rotigotine—Visual impairment—Fludarabine—lymphatic system cancer	0.00345	0.00701	CcSEcCtD
Rotigotine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00341	0.00693	CcSEcCtD
Rotigotine—Agitation—Teniposide—lymphatic system cancer	0.00325	0.00662	CcSEcCtD
Rotigotine—Malnutrition—Fludarabine—lymphatic system cancer	0.00311	0.00633	CcSEcCtD
Rotigotine—Hypertension—Teniposide—lymphatic system cancer	0.00306	0.00622	CcSEcCtD
Rotigotine—Weight decreased—Bleomycin—lymphatic system cancer	0.00296	0.00603	CcSEcCtD
Rotigotine—Confusional state—Teniposide—lymphatic system cancer	0.00291	0.00593	CcSEcCtD
Rotigotine—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00289	0.00587	CcSEcCtD
Rotigotine—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00289	0.00587	CcSEcCtD
Rotigotine—Infection—Teniposide—lymphatic system cancer	0.00287	0.00584	CcSEcCtD
Rotigotine—Agitation—Fludarabine—lymphatic system cancer	0.00286	0.00582	CcSEcCtD
Rotigotine—Malaise—Fludarabine—lymphatic system cancer	0.00281	0.00571	CcSEcCtD
Rotigotine—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00279	0.00568	CcSEcCtD
Rotigotine—Pruritus—Mechlorethamine—lymphatic system cancer	0.00277	0.00564	CcSEcCtD
Rotigotine—Anorexia—Teniposide—lymphatic system cancer	0.00275	0.0056	CcSEcCtD
Rotigotine—Cough—Fludarabine—lymphatic system cancer	0.00272	0.00552	CcSEcCtD
Rotigotine—Hypotension—Teniposide—lymphatic system cancer	0.0027	0.00549	CcSEcCtD
Rotigotine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00268	0.00546	CcSEcCtD
Rotigotine—Arthralgia—Fludarabine—lymphatic system cancer	0.00265	0.00539	CcSEcCtD
Rotigotine—Discomfort—Fludarabine—lymphatic system cancer	0.00262	0.00532	CcSEcCtD
Rotigotine—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00259	0.00527	CcSEcCtD
Rotigotine—Confusional state—Fludarabine—lymphatic system cancer	0.00256	0.00521	CcSEcCtD
Rotigotine—Depression—Carmustine—lymphatic system cancer	0.00254	0.00517	CcSEcCtD
Rotigotine—Infection—Fludarabine—lymphatic system cancer	0.00252	0.00513	CcSEcCtD
Rotigotine—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00251	0.00511	CcSEcCtD
Rotigotine—Decreased appetite—Teniposide—lymphatic system cancer	0.00251	0.00511	CcSEcCtD
Rotigotine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00249	0.00507	CcSEcCtD
Rotigotine—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00249	0.00507	CcSEcCtD
Rotigotine—Rash—Mechlorethamine—lymphatic system cancer	0.00247	0.00503	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.00247	0.00502	CcSEcCtD
Rotigotine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00247	0.00502	CcSEcCtD
Rotigotine—Weight decreased—Vincristine—lymphatic system cancer	0.00247	0.00502	CcSEcCtD
Rotigotine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00246	0.00499	CcSEcCtD
Rotigotine—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.00245	0.00498	CcSEcCtD
Rotigotine—Depression—Vincristine—lymphatic system cancer	0.00243	0.00493	CcSEcCtD
Rotigotine—Anorexia—Fludarabine—lymphatic system cancer	0.00242	0.00492	CcSEcCtD
Rotigotine—Weight increased—Mitoxantrone—lymphatic system cancer	0.00242	0.00492	CcSEcCtD
Rotigotine—Weight decreased—Mitoxantrone—lymphatic system cancer	0.0024	0.00489	CcSEcCtD
Rotigotine—Feeling abnormal—Teniposide—lymphatic system cancer	0.00238	0.00484	CcSEcCtD
Rotigotine—Nausea—Mechlorethamine—lymphatic system cancer	0.00233	0.00474	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00231	0.00471	CcSEcCtD
Rotigotine—Urticaria—Teniposide—lymphatic system cancer	0.0023	0.00467	CcSEcCtD
Rotigotine—Erythema—Bleomycin—lymphatic system cancer	0.00228	0.00464	CcSEcCtD
Rotigotine—Paraesthesia—Fludarabine—lymphatic system cancer	0.00228	0.00464	CcSEcCtD
Rotigotine—Hallucination—Carmustine—lymphatic system cancer	0.00228	0.00463	CcSEcCtD
Rotigotine—Oedema peripheral—Carmustine—lymphatic system cancer	0.00225	0.00458	CcSEcCtD
Rotigotine—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00225	0.00457	CcSEcCtD
Rotigotine—Dyspepsia—Fludarabine—lymphatic system cancer	0.00224	0.00455	CcSEcCtD
Rotigotine—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00222	0.00452	CcSEcCtD
Rotigotine—Decreased appetite—Fludarabine—lymphatic system cancer	0.00221	0.00449	CcSEcCtD
Rotigotine—Visual impairment—Carmustine—lymphatic system cancer	0.0022	0.00448	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00219	0.00446	CcSEcCtD
Rotigotine—Fatigue—Fludarabine—lymphatic system cancer	0.00219	0.00445	CcSEcCtD
Rotigotine—Inflammation—Methotrexate—lymphatic system cancer	0.00218	0.00443	CcSEcCtD
Rotigotine—Hallucination—Vincristine—lymphatic system cancer	0.00217	0.00442	CcSEcCtD
Rotigotine—Constipation—Fludarabine—lymphatic system cancer	0.00217	0.00442	CcSEcCtD
Rotigotine—Pain—Fludarabine—lymphatic system cancer	0.00217	0.00442	CcSEcCtD
Rotigotine—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00215	0.00437	CcSEcCtD
Rotigotine—Hypersensitivity—Teniposide—lymphatic system cancer	0.00213	0.00433	CcSEcCtD
Rotigotine—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00212	0.00431	CcSEcCtD
Rotigotine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00209	0.00426	CcSEcCtD
Rotigotine—Asthenia—Teniposide—lymphatic system cancer	0.00207	0.00422	CcSEcCtD
Rotigotine—Malaise—Bleomycin—lymphatic system cancer	0.00206	0.00419	CcSEcCtD
Rotigotine—Pruritus—Teniposide—lymphatic system cancer	0.00204	0.00416	CcSEcCtD
Rotigotine—Skin exfoliation—Methotrexate—lymphatic system cancer	0.00201	0.0041	CcSEcCtD
Rotigotine—Mental disorder—Carmustine—lymphatic system cancer	0.002	0.00408	CcSEcCtD
Rotigotine—Erythema—Carmustine—lymphatic system cancer	0.00199	0.00405	CcSEcCtD
Rotigotine—Malnutrition—Carmustine—lymphatic system cancer	0.00199	0.00405	CcSEcCtD
Rotigotine—Cough—Bleomycin—lymphatic system cancer	0.00199	0.00405	CcSEcCtD
Rotigotine—Angiopathy—Vincristine—lymphatic system cancer	0.00198	0.00403	CcSEcCtD
Rotigotine—Diarrhoea—Teniposide—lymphatic system cancer	0.00198	0.00402	CcSEcCtD
Rotigotine—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00197	0.004	CcSEcCtD
Rotigotine—Discomfort—Bleomycin—lymphatic system cancer	0.00192	0.0039	CcSEcCtD
Rotigotine—Mental disorder—Vincristine—lymphatic system cancer	0.00191	0.00389	CcSEcCtD
Rotigotine—Confusional state—Bleomycin—lymphatic system cancer	0.00188	0.00382	CcSEcCtD
Rotigotine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00187	0.00381	CcSEcCtD
Rotigotine—Tremor—Carmustine—lymphatic system cancer	0.00187	0.0038	CcSEcCtD
Rotigotine—Erythema—Mitoxantrone—lymphatic system cancer	0.00185	0.00377	CcSEcCtD
Rotigotine—Infection—Bleomycin—lymphatic system cancer	0.00185	0.00376	CcSEcCtD
Rotigotine—Vomiting—Teniposide—lymphatic system cancer	0.00184	0.00374	CcSEcCtD
Rotigotine—Agitation—Carmustine—lymphatic system cancer	0.00183	0.00372	CcSEcCtD
Rotigotine—Asthenia—Fludarabine—lymphatic system cancer	0.00182	0.00371	CcSEcCtD
Rotigotine—Rash—Teniposide—lymphatic system cancer	0.00182	0.00371	CcSEcCtD
Rotigotine—Dermatitis—Teniposide—lymphatic system cancer	0.00182	0.0037	CcSEcCtD
Rotigotine—Headache—Teniposide—lymphatic system cancer	0.00181	0.00368	CcSEcCtD
Rotigotine—Pruritus—Fludarabine—lymphatic system cancer	0.0018	0.00366	CcSEcCtD
Rotigotine—Anorexia—Bleomycin—lymphatic system cancer	0.00178	0.00361	CcSEcCtD
Rotigotine—Agitation—Vincristine—lymphatic system cancer	0.00175	0.00355	CcSEcCtD
Rotigotine—Hypotension—Bleomycin—lymphatic system cancer	0.00174	0.00354	CcSEcCtD
Rotigotine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00174	0.00353	CcSEcCtD
Rotigotine—Hypertension—Carmustine—lymphatic system cancer	0.00172	0.0035	CcSEcCtD
Rotigotine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00172	0.00349	CcSEcCtD
Rotigotine—Nausea—Teniposide—lymphatic system cancer	0.00172	0.00349	CcSEcCtD
Rotigotine—Vertigo—Vincristine—lymphatic system cancer	0.00171	0.00347	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.0017	0.00345	CcSEcCtD
Rotigotine—Paraesthesia—Bleomycin—lymphatic system cancer	0.00167	0.0034	CcSEcCtD
Rotigotine—Malaise—Mitoxantrone—lymphatic system cancer	0.00167	0.0034	CcSEcCtD
Rotigotine—Hypertension—Vincristine—lymphatic system cancer	0.00164	0.00334	CcSEcCtD
Rotigotine—Confusional state—Carmustine—lymphatic system cancer	0.00164	0.00333	CcSEcCtD
Rotigotine—Decreased appetite—Bleomycin—lymphatic system cancer	0.00162	0.00329	CcSEcCtD
Rotigotine—Cough—Mitoxantrone—lymphatic system cancer	0.00162	0.00329	CcSEcCtD
Rotigotine—Infection—Carmustine—lymphatic system cancer	0.00161	0.00328	CcSEcCtD
Rotigotine—Vomiting—Fludarabine—lymphatic system cancer	0.00161	0.00328	CcSEcCtD
Rotigotine—Rash—Fludarabine—lymphatic system cancer	0.0016	0.00326	CcSEcCtD
Rotigotine—Dermatitis—Fludarabine—lymphatic system cancer	0.0016	0.00325	CcSEcCtD
Rotigotine—Hypertension—Mitoxantrone—lymphatic system cancer	0.0016	0.00325	CcSEcCtD
Rotigotine—Pain—Bleomycin—lymphatic system cancer	0.00159	0.00324	CcSEcCtD
Rotigotine—Headache—Fludarabine—lymphatic system cancer	0.00159	0.00324	CcSEcCtD
Rotigotine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00158	0.00321	CcSEcCtD
Rotigotine—Lethargy—Methotrexate—lymphatic system cancer	0.00156	0.00318	CcSEcCtD
Rotigotine—Discomfort—Mitoxantrone—lymphatic system cancer	0.00156	0.00317	CcSEcCtD
Rotigotine—Anorexia—Carmustine—lymphatic system cancer	0.00155	0.00315	CcSEcCtD
Rotigotine—Infection—Vincristine—lymphatic system cancer	0.00154	0.00314	CcSEcCtD
Rotigotine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00153	0.00312	CcSEcCtD
Rotigotine—Confusional state—Mitoxantrone—lymphatic system cancer	0.00152	0.0031	CcSEcCtD
Rotigotine—Nervous system disorder—Vincristine—lymphatic system cancer	0.00152	0.0031	CcSEcCtD
Rotigotine—Hypotension—Carmustine—lymphatic system cancer	0.00152	0.00309	CcSEcCtD
Rotigotine—Nausea—Fludarabine—lymphatic system cancer	0.00151	0.00307	CcSEcCtD
Rotigotine—Infection—Mitoxantrone—lymphatic system cancer	0.0015	0.00305	CcSEcCtD
Rotigotine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.0015	0.00305	CcSEcCtD
Rotigotine—Shock—Mitoxantrone—lymphatic system cancer	0.00149	0.00302	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00148	0.00301	CcSEcCtD
Rotigotine—Urticaria—Bleomycin—lymphatic system cancer	0.00148	0.00301	CcSEcCtD
Rotigotine—Anorexia—Vincristine—lymphatic system cancer	0.00148	0.00301	CcSEcCtD
Rotigotine—Insomnia—Carmustine—lymphatic system cancer	0.00147	0.00299	CcSEcCtD
Rotigotine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00147	0.00299	CcSEcCtD
Rotigotine—Irritability—Methotrexate—lymphatic system cancer	0.00146	0.00297	CcSEcCtD
Rotigotine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00146	0.00297	CcSEcCtD
Rotigotine—Paraesthesia—Carmustine—lymphatic system cancer	0.00146	0.00297	CcSEcCtD
Rotigotine—Hypotension—Vincristine—lymphatic system cancer	0.00145	0.00295	CcSEcCtD
Rotigotine—Somnolence—Carmustine—lymphatic system cancer	0.00145	0.00294	CcSEcCtD
Rotigotine—Anorexia—Mitoxantrone—lymphatic system cancer	0.00144	0.00293	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00141	0.00288	CcSEcCtD
Rotigotine—Decreased appetite—Carmustine—lymphatic system cancer	0.00141	0.00287	CcSEcCtD
Rotigotine—Hypotension—Mitoxantrone—lymphatic system cancer	0.00141	0.00287	CcSEcCtD
Rotigotine—Insomnia—Vincristine—lymphatic system cancer	0.0014	0.00285	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.0014	0.00285	CcSEcCtD
Rotigotine—Paraesthesia—Vincristine—lymphatic system cancer	0.00139	0.00283	CcSEcCtD
Rotigotine—Constipation—Carmustine—lymphatic system cancer	0.00139	0.00283	CcSEcCtD
Rotigotine—Pain—Carmustine—lymphatic system cancer	0.00139	0.00283	CcSEcCtD
Rotigotine—Breast disorder—Methotrexate—lymphatic system cancer	0.00138	0.00282	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00138	0.0028	CcSEcCtD
Rotigotine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00137	0.00279	CcSEcCtD
Rotigotine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00136	0.00276	CcSEcCtD
Rotigotine—Decreased appetite—Vincristine—lymphatic system cancer	0.00135	0.00274	CcSEcCtD
Rotigotine—Somnolence—Mitoxantrone—lymphatic system cancer	0.00134	0.00273	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00134	0.00272	CcSEcCtD
Rotigotine—Feeling abnormal—Carmustine—lymphatic system cancer	0.00134	0.00272	CcSEcCtD
Rotigotine—Fatigue—Vincristine—lymphatic system cancer	0.00134	0.00272	CcSEcCtD
Rotigotine—Asthenia—Bleomycin—lymphatic system cancer	0.00134	0.00272	CcSEcCtD
Rotigotine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00133	0.00271	CcSEcCtD
Rotigotine—Pain—Vincristine—lymphatic system cancer	0.00133	0.0027	CcSEcCtD
Rotigotine—Constipation—Vincristine—lymphatic system cancer	0.00133	0.0027	CcSEcCtD
Rotigotine—Pruritus—Bleomycin—lymphatic system cancer	0.00132	0.00268	CcSEcCtD
Rotigotine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00131	0.00267	CcSEcCtD
Rotigotine—Fatigue—Mitoxantrone—lymphatic system cancer	0.0013	0.00265	CcSEcCtD
Rotigotine—Pain—Mitoxantrone—lymphatic system cancer	0.00129	0.00263	CcSEcCtD
Rotigotine—Constipation—Mitoxantrone—lymphatic system cancer	0.00129	0.00263	CcSEcCtD
Rotigotine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00125	0.00253	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00123	0.0025	CcSEcCtD
Rotigotine—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00122	0.00248	CcSEcCtD
Rotigotine—Urticaria—Mitoxantrone—lymphatic system cancer	0.0012	0.00244	CcSEcCtD
Rotigotine—Hypersensitivity—Carmustine—lymphatic system cancer	0.0012	0.00244	CcSEcCtD
Rotigotine—Vomiting—Bleomycin—lymphatic system cancer	0.00118	0.00241	CcSEcCtD
Rotigotine—Infestation NOS—Methotrexate—lymphatic system cancer	0.00118	0.0024	CcSEcCtD
Rotigotine—Infestation—Methotrexate—lymphatic system cancer	0.00118	0.0024	CcSEcCtD
Rotigotine—Depression—Methotrexate—lymphatic system cancer	0.00118	0.00239	CcSEcCtD
Rotigotine—Rash—Bleomycin—lymphatic system cancer	0.00117	0.00239	CcSEcCtD
Rotigotine—Dermatitis—Bleomycin—lymphatic system cancer	0.00117	0.00239	CcSEcCtD
Rotigotine—Asthenia—Carmustine—lymphatic system cancer	0.00117	0.00237	CcSEcCtD
Rotigotine—Hypersensitivity—Vincristine—lymphatic system cancer	0.00114	0.00233	CcSEcCtD
Rotigotine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00111	0.00226	CcSEcCtD
Rotigotine—Asthenia—Vincristine—lymphatic system cancer	0.00111	0.00226	CcSEcCtD
Rotigotine—Diarrhoea—Carmustine—lymphatic system cancer	0.00111	0.00226	CcSEcCtD
Rotigotine—Nausea—Bleomycin—lymphatic system cancer	0.00111	0.00225	CcSEcCtD
Rotigotine—Asthenia—Mitoxantrone—lymphatic system cancer	0.00108	0.00221	CcSEcCtD
Rotigotine—Dizziness—Carmustine—lymphatic system cancer	0.00107	0.00219	CcSEcCtD
Rotigotine—Diarrhoea—Vincristine—lymphatic system cancer	0.00106	0.00216	CcSEcCtD
Rotigotine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00103	0.0021	CcSEcCtD
Rotigotine—Vomiting—Carmustine—lymphatic system cancer	0.00103	0.0021	CcSEcCtD
Rotigotine—Dizziness—Vincristine—lymphatic system cancer	0.00103	0.00209	CcSEcCtD
Rotigotine—Rash—Carmustine—lymphatic system cancer	0.00102	0.00208	CcSEcCtD
Rotigotine—Dermatitis—Carmustine—lymphatic system cancer	0.00102	0.00208	CcSEcCtD
Rotigotine—Visual impairment—Methotrexate—lymphatic system cancer	0.00102	0.00208	CcSEcCtD
Rotigotine—Headache—Carmustine—lymphatic system cancer	0.00102	0.00207	CcSEcCtD
Rotigotine—Tinnitus—Methotrexate—lymphatic system cancer	0.000988	0.00201	CcSEcCtD
Rotigotine—Vomiting—Vincristine—lymphatic system cancer	0.000987	0.00201	CcSEcCtD
Rotigotine—Rash—Vincristine—lymphatic system cancer	0.000978	0.00199	CcSEcCtD
Rotigotine—Dermatitis—Vincristine—lymphatic system cancer	0.000977	0.00199	CcSEcCtD
Rotigotine—Headache—Vincristine—lymphatic system cancer	0.000972	0.00198	CcSEcCtD
Rotigotine—Nausea—Carmustine—lymphatic system cancer	0.000966	0.00196	CcSEcCtD
Rotigotine—Angiopathy—Methotrexate—lymphatic system cancer	0.000961	0.00196	CcSEcCtD
Rotigotine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000961	0.00195	CcSEcCtD
Rotigotine—Immune system disorder—Methotrexate—lymphatic system cancer	0.000957	0.00195	CcSEcCtD
Rotigotine—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000955	0.00194	CcSEcCtD
Rotigotine—Rash—Mitoxantrone—lymphatic system cancer	0.000953	0.00194	CcSEcCtD
Rotigotine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000952	0.00194	CcSEcCtD
Rotigotine—Headache—Mitoxantrone—lymphatic system cancer	0.000947	0.00193	CcSEcCtD
Rotigotine—Mental disorder—Methotrexate—lymphatic system cancer	0.000928	0.00189	CcSEcCtD
Rotigotine—Erythema—Methotrexate—lymphatic system cancer	0.000923	0.00188	CcSEcCtD
Rotigotine—Malnutrition—Methotrexate—lymphatic system cancer	0.000923	0.00188	CcSEcCtD
Rotigotine—Nausea—Vincristine—lymphatic system cancer	0.000922	0.00187	CcSEcCtD
Rotigotine—Nausea—Mitoxantrone—lymphatic system cancer	0.000898	0.00183	CcSEcCtD
Rotigotine—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000856	0.00174	CcSEcCtD
Rotigotine—Malaise—Methotrexate—lymphatic system cancer	0.000832	0.00169	CcSEcCtD
Rotigotine—Vertigo—Methotrexate—lymphatic system cancer	0.000829	0.00169	CcSEcCtD
Rotigotine—Cough—Methotrexate—lymphatic system cancer	0.000805	0.00164	CcSEcCtD
Rotigotine—Arthralgia—Methotrexate—lymphatic system cancer	0.000785	0.0016	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.00078	0.00159	CcSEcCtD
Rotigotine—Discomfort—Methotrexate—lymphatic system cancer	0.000776	0.00158	CcSEcCtD
Rotigotine—Confusional state—Methotrexate—lymphatic system cancer	0.000759	0.00154	CcSEcCtD
Rotigotine—Infection—Methotrexate—lymphatic system cancer	0.000748	0.00152	CcSEcCtD
Rotigotine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000738	0.0015	CcSEcCtD
Rotigotine—Skin disorder—Methotrexate—lymphatic system cancer	0.000731	0.00149	CcSEcCtD
Rotigotine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000728	0.00148	CcSEcCtD
Rotigotine—Anorexia—Methotrexate—lymphatic system cancer	0.000718	0.00146	CcSEcCtD
Rotigotine—Hypotension—Methotrexate—lymphatic system cancer	0.000704	0.00143	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000686	0.0014	CcSEcCtD
Rotigotine—Insomnia—Methotrexate—lymphatic system cancer	0.000681	0.00139	CcSEcCtD
Rotigotine—Paraesthesia—Methotrexate—lymphatic system cancer	0.000676	0.00138	CcSEcCtD
Rotigotine—Somnolence—Methotrexate—lymphatic system cancer	0.000669	0.00136	CcSEcCtD
Rotigotine—Dyspepsia—Methotrexate—lymphatic system cancer	0.000663	0.00135	CcSEcCtD
Rotigotine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000654	0.00133	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00065	0.00132	CcSEcCtD
Rotigotine—Fatigue—Methotrexate—lymphatic system cancer	0.000649	0.00132	CcSEcCtD
Rotigotine—Pain—Methotrexate—lymphatic system cancer	0.000644	0.00131	CcSEcCtD
Rotigotine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00062	0.00126	CcSEcCtD
Rotigotine—Urticaria—Methotrexate—lymphatic system cancer	0.000598	0.00122	CcSEcCtD
Rotigotine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000555	0.00113	CcSEcCtD
Rotigotine—Asthenia—Methotrexate—lymphatic system cancer	0.00054	0.0011	CcSEcCtD
Rotigotine—Pruritus—Methotrexate—lymphatic system cancer	0.000533	0.00108	CcSEcCtD
Rotigotine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000515	0.00105	CcSEcCtD
Rotigotine—Dizziness—Methotrexate—lymphatic system cancer	0.000498	0.00101	CcSEcCtD
Rotigotine—Vomiting—Methotrexate—lymphatic system cancer	0.000479	0.000974	CcSEcCtD
Rotigotine—Rash—Methotrexate—lymphatic system cancer	0.000475	0.000966	CcSEcCtD
Rotigotine—Dermatitis—Methotrexate—lymphatic system cancer	0.000474	0.000965	CcSEcCtD
Rotigotine—Headache—Methotrexate—lymphatic system cancer	0.000472	0.000959	CcSEcCtD
Rotigotine—Nausea—Methotrexate—lymphatic system cancer	0.000447	0.00091	CcSEcCtD
